Substitute for Raised S.B. No. 202
Session Year 2024


AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING PRESCRIPTION DRUG CONTROL.

To: (1) Allow a licensed manufacturer or wholesaler to sell a hypodermic needle or syringe to an advanced practice registered nurse, optometrist or physician assistant; (2) redefine "commissioner", "pharmaceutical manufacturer" and "pharmaceutical marketing firm" for the purposes of various statutes concerning pharmaceutical marketing; (3) eliminate a requirement that the Department of Consumer Protection annually analyze certain information submitted to the department concerning pharmaceutical marketing; (4) extend the date by which the department is required to submit an annual report concerning pharmaceutical marketing; (5) eliminate an overlapping prohibition concerning automatic reciprocal discipline of pharmacists; (6) modify the actions the Commissioner of Consumer Protection may take following a violation of certain statutes concerning pharmaceutical marketing; (7) require certain practitioners that dispense, administer or prescribe controlled substances to make certain records available to the department; and (8) make minor, technical and conforming changes to various statutes concerning prescription drug control.


Other Bills with Similar Topics

  Consumer Protection Department 

  Controlled substances 

  Drugs 

  Marketing 

  Medical personnel 

  Pharmacists 

  Physicians 

  Professional licenses 

  Salespersons 

  Pharmaceutical manufacturing companies